Abstract: The invention relates to an end plate for filter material (10) for filtering a liquid, particularly a hydraulic oil, having a through opening (11) for filtered liquid, which is surrounded by a sealing ring (20) for a connecting piece, and a cover (12) for the filter material (10). The invention is characterized in that the sealing ring (20) delimits a free space (13) for accommodating an anti-rotation lock (14) of a switch (15) and/or a bypass valve (16) of a filter system (30). Furthermore, the invention relates to a filter element, a filter system and a method for filtering liquid.

Abstract: The invention relates to an end plate for filter material (10) for filtering a liquid, particularly a hydraulic oil, having a through opening (11) for filtered liquid, which is surrounded by a sealing ring (20) for a connecting piece, and a cover (12) for the filter material (10). The invention is characterized in that the sealing ring (20) delimits a free space (13) for accommodating an anti-rotation lock (14) of a switch (15) and/or a bypass valve (16) of a filter system (30). Furthermore, the invention relates to a filter element, a filter system and a method for filtering liquid.

Abstract: An end plate for filter material for filtering a liquid, particularly a hydraulic oil, having a through opening for filtered liquid, which is surrounded by a sealing ring for a connecting piece, and a cover for the filter material. The sealing ring delimits a free space for accommodating an anti-rotation lock of a switch and/or a bypass valve of a filter system. Furthermore, a filter element, a filter system and a method for filtering liquid are also disclosed.

Abstract: The invention relates to foam materials that are resistant to high temperatures, to the production of same from aromatic polyisocyanates and polyepoxides, and to the use of said foam materials.

Abstract: The invention relates to foam materials that are resistant to high temperatures, to the production of same from aromatic polyisocyanates and polyepoxides, and to the use of said foam materials.

Abstract: The present invention relates to chromogenic and fluorogenic substrates that can be used for the highly sensitive and selective detection of the activity of serine proteases. The present invention further relates to methods for the detection of the activity of serine proteases, said methods using the substrates of the present invention. Furthermore, the present invention relates to diagnostic kits and test strips using the above substrates, as well as uses of said substrates.

Abstract: The invention relates to high-temperature-resistant foams having excellent flame retardancy, to the production thereof from organic polyisocyanates and polyepoxides, and to the use of said foams.

Abstract: The invention relates to temperature-resistant foams with a high degree of flame resistance, to the production of same from aromatic isocyanates and polyepoxides using incorporable catalysts and with formic acid as a blowing agent, and to the use of said foams.

Abstract: The present invention relates to a method for detecting at least one direct factor Xa inhibitor in a sample other than citrate plasma, comprising the step of mixing a sample containing a factor Xa inhibitor with a composition containing factor Xa under conditions which allow the factor Xa to release a detectable substance from a chromogenic substrate.

Abstract: The present invention relates to a method for detecting at least one direct factor Xa inhibitor in a sample other than citrate plasma, comprising the step of mixing a sample containing a factor Xa inhibitor with a composition containing factor Xa under conditions which allow the factor Xa to release a detectable substance from a chromogenic substrate.

Abstract: In some example embodiments, a computerized method includes receiving multiple documents from at least one machine-readable media. The multiple documents have a hierarchical relationship relative to each other. The multiple documents include a first document, wherein a second document of the multiple documents comprises an enhancement to first document. The enhancement is at least one of a replacement of part of the first document or an addition to the first document. The computerized method includes displaying the multiple documents on a display screen such that the multiple documents are arranged according to the hierarchical relationship.

Abstract: The present invention relates to a method for detecting at least one direct factor Xa inhibitor in a sample other than citrate plasma, comprising the step of mixing a sample containing a factor Xa inhibitor with a composition containing factor Xa under conditions which allow the factor Xa to release a detectable substance from a chromogenic substrate.

Abstract: The present invention relates to a method for detecting at least one direct factor Xa inhibitor in a sample other than citrate plasma, comprising the step of mixing a sample containing a factor Xa inhibitor with a composition containing factor Xa under conditions which allow the factor Xa to release a detectable substance from a chromogenic substrate.

Abstract: The present invention relates to a method for detecting at least one direct factor Xa inhibitor in a sample other than citrate plasma, comprising the step of mixing a sample containing a factor Xa inhibitor with a composition containing factor Xa under conditions which allow the factor Xa to release a detectable substance from a chromogenic substrate.

Abstract: The invention relates to a perylene diimide derivative and to an in vitro method for preparing the same. In addition, the invention relates to a method for detecting heparin in a sample using perylene diimide derivatives, wherein the interaction of the perylene diimide derivative with heparin modulates the intensity of the fluorescent signal of the mixture compared to the solution. The invention also comprises a diagnostic kit for detecting heparin in a sample in vitro, comprising the perylene diimide derivative, as well as the use of the perylene diimide derivative for neutralizing the anticoagulant activity of heparin.

Abstract: The present invention relates to a method for detecting at least one direct factor Xa inhibitor in a sample other than citrate plasma, comprising the step of mixing a sample containing a factor Xa inhibitor with a composition containing factor Xa under conditions which allow the factor Xa to release a detectable substance from a chromogenic substrate.

Abstract: The invention relates to a perylene diimide derivative and to an in vitro method for preparing the same. In addition, the invention relates to a method for detecting heparin in a sample using perylene diimide derivatives, wherein the interaction of the perylene diimide derivative with heparin modulates the intensity of the fluorescent signal of the mixture compared to the solution. The invention also comprises a diagnostic kit for detecting heparin in a sample in vitro, comprising the perylene diimide derivative, as well as the use of the perylene diimide derivative for neutralizing the anticoagulant activity of heparin.

Abstract: The present invention relates to anthraquinone derivatives which act as a fluorophore, to a process for producing said anthraquinone derivatives and their use as fluorophores for staining membranes in live or fixed cells.

Abstract: In some example embodiments, a computerized method includes receiving multiple documents from at least one machine-readable media. The multiple documents have a hierarchical relationship relative to each other. The multiple documents include a first document, wherein a second document of the multiple documents comprises an enhancement to first document. The enhancement is at least one of a replacement of part of the first document or an addition to the first document. The computerized method includes displaying the multiple documents on a display screen such that the multiple documents are arranged according to the hierarchical relationship.

Abstract: The present invention relates to anthraquinone derivatives which act as a fluorophore, to a process for producing said anthraquinone derivatives and their use as fluorophores for staining membranes in live or fixed cells.